Kazuyoshi Katayanagi
Kazuyoshi Katayanagi publishes mostly in Surgery, Pulmonary and Respiratory Medicine and Oncology, on topics such as Gastric Cancer Management and Outcomes, Liver Disease Diagnosis and Treatment and Pediatric Hepatobiliary Diseases and Treatments.
- World rank
- #1,910,485 of 7,710,434 ranked researchers
- Rank in Japan
- #33,935 of 383,136
- Works
- 70
- Citations
- 3.2k
- Citations per work
- 46.3
What does Kazuyoshi Katayanagi research?
Kazuyoshi Katayanagi's work is mostly in Medicine (72%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences5172.2%
- Medicine5172.2%
- Everything else1927.8%
- 1Surgery26% of their works
- 2Pulmonary and Respiratory Medicine17% of their works
- 3Oncology10% of their works
- 4Epidemiology8% of their works
- 5Rheumatology6% of their works
- 6Hepatology6% of their works
Research topics
- Gastric Cancer Management and Outcomes
- Liver Disease Diagnosis and Treatment
- Pediatric Hepatobiliary Diseases and Treatments
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Esophageal Cancer Research and Treatment
- Pancreatic and Hepatic Oncology Research
- IgG4-Related and Inflammatory Diseases
- Helicobacter pylori-related gastroenterology studies
Which keywords describe Kazuyoshi Katayanagi's research?
The keywords of their largest research topics: Endoscopic Resection, Chemotherapy, Gastric Cancer, Epidemiology, Inflammation, Neoadjuvant Therapy, Lymph Node Dissection and Molecular Characterization.
- Surgical Complications
- IgG4-Related Disease
- Autoimmune Pancreatitis
- Preoperative Chemoradiotherapy
- Cholangiocarcinoma
- NASH
- Biliary Atresia
- Molecular Characterization
- Neoadjuvant Therapy
- Epidemiology
- Chemotherapy
- Endoscopic Resection
- Gastric Cancer
- Inflammation
- Lymph Node Dissection
- Alagille Syndrome
- NAFLD
- Biliary Tract Cancer
- Esophageal Carcinoma
- Antibiotic Resistance
- Helicobacter pylori
- Pancreatic Cancer
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 22 words, with their numbers
- Endoscopic Resection162 topics
- Chemotherapy152 topics
- Gastric Cancer152 topics
- Epidemiology142 topics
- Inflammation142 topics
- Neoadjuvant Therapy112 topics
- Lymph Node Dissection101 topic
- Molecular Characterization101 topic
- Alagille Syndrome91 topic
- Biliary Atresia91 topic
- NAFLD91 topic
- NASH91 topic
- Biliary Tract Cancer81 topic
- Cholangiocarcinoma81 topic
- Esophageal Carcinoma61 topic
- Preoperative Chemoradiotherapy61 topic
- Antibiotic Resistance51 topic
- Autoimmune Pancreatitis51 topic
- Helicobacter pylori51 topic
- IgG4-Related Disease51 topic
- Pancreatic Cancer51 topic
- Surgical Complications51 topic
Where does Kazuyoshi Katayanagi work?
Kazuyoshi Katayanagi's main affiliation in the publication record is Ishikawa Prefectural Central Hospital, Japan.
How many publications and citations does Kazuyoshi Katayanagi have?
OpenAlex counts 70 works and 3,238 citations for Kazuyoshi Katayanagi, an h-index of 24, ranking #1,910,485 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Kazuyoshi Katayanagi. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.